Mutations in KRAS: are they a valid biomarker for pancreatic ductal adenocarcinomas diagnosis?

Vilvapathy Narayanan, Sergey Konstantinov, Maikel Peppelenbosch

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageUndefined/Unknown
Pages (from-to)S72-S77
JournalTranslational Cancer Research
Volume6
DOIs
Publication statusPublished - 2017

Research programs

  • EMC OR-01

Cite this